Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primary Prevention of Postpartum Hemorrhage in Intrapartum Cesarean Section Versus Intravenous Carbetocin Alone

Inclusion Criteria: * Women undergoing C-Sections. * Women between the ages of 18 and 45 years. * Singleton pregnancy. * Gestational age is equal to or more than 36 weeks. * No known coagulopathy or bleeding disorders. * No known hypersensitivity or allergy to drugs used in the study. * Normal obstetric ultrasonography with no fetal abnormalities. Exclusion Criteria: * Hemodynamically unstable or immobile patients. * Multifetal pregnancy. * Patients who are receiving prophylactic or therapeutic anticoagulation. * Known comorbidities and contraindications to the use of Ergot derivatives or Carbetocin such as hypertension or cardiovascular disorders. * Placenta previa and/or Placenta accreta spectrum. * History of thromboembolism. * Preeclampsia or eclampsia. * Any additional measurements needed to control or stop excessive bleeding intraoperatively such as uterine artery ligation or use of sterile gelatin absorbable foam.